Kenneth C. Cundy - 29 Feb 2024 Form 4 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Chief Scientific Officer
Signature
/s/ Kenneth C. Cundy
Issuer symbol
ANEB
Transactions as of
29 Feb 2024
Net transactions value
$0
Form type
4
Filing time
01 Mar 2024, 18:24:37 UTC
Previous filing
13 Dec 2022
Next filing
07 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANEB Stock Option (right to buy) Award $0 +72,613 $0.000000 72,613 29 Feb 2024 Common Stock 72,613 $2.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vest in a series of sixteen (16) equal quarterly installments on the first day of each calendar quarter, commencing with the first day of the calendar quarter beginning on April 1, 2024.